BACKGROUND: In adults with chronic kidney disease (CKD), cigarette smoking is associated with an increased risk for CKD progression and transplant failure. In children, secondhand smoke (SHS) exposure has been associated with elevated blood pressure. There are no studies on the prevalence and effect of SHS exposure in CKD. METHODS: Subjects were enrolled in the Chronic Kidney Disease in Children (CKiD) Study, an observational cohort of 366 children aged 1 to 16 years with CKD. Secondhand smoke exposure was obtained via questionnaire. SHS exposure was also determined based on urine cotinine (Ucot) measurements (1 ng/mL ≤ Ucot < 75 ng/mL). The cross-sectional association of SHS exposure with proteinuria was assessed. RESULTS: Using Ucot, 22 % of subjects were exposed to SHS. SHS exposure was significantly associated with lower maternal education and African American race, and a greater prevalence of nephrotic range proteinuria and left ventricular hypertrophy. In a multivariate model (including sex, age, race, maternal education, income level, private insurance status, abnormal birth history and CKD diagnosis), the prevalence odds of nephrotic range proteinuria was 2.64, (95 % confidence interval 1.08, 6.42) higher in children exposed to SHS compared to those unexposed. CONCLUSIONS: In our cohort of children with CKD, SHS exposure was common (22 %) and independently associated with nephrotic range proteinuria. Exposure to SHS may be an important factor to consider in CKD progression.
BACKGROUND: In adults with chronic kidney disease (CKD), cigarette smoking is associated with an increased risk for CKD progression and transplant failure. In children, secondhand smoke (SHS) exposure has been associated with elevated blood pressure. There are no studies on the prevalence and effect of SHS exposure in CKD. METHODS: Subjects were enrolled in the Chronic Kidney Disease in Children (CKiD) Study, an observational cohort of 366 children aged 1 to 16 years with CKD. Secondhand smoke exposure was obtained via questionnaire. SHS exposure was also determined based on urine cotinine (Ucot) measurements (1 ng/mL ≤ Ucot < 75 ng/mL). The cross-sectional association of SHS exposure with proteinuria was assessed. RESULTS: Using Ucot, 22 % of subjects were exposed to SHS. SHS exposure was significantly associated with lower maternal education and African American race, and a greater prevalence of nephrotic range proteinuria and left ventricular hypertrophy. In a multivariate model (including sex, age, race, maternal education, income level, private insurance status, abnormal birth history and CKD diagnosis), the prevalence odds of nephrotic range proteinuria was 2.64, (95 % confidence interval 1.08, 6.42) higher in children exposed to SHS compared to those unexposed. CONCLUSIONS: In our cohort of children with CKD, SHS exposure was common (22 %) and independently associated with nephrotic range proteinuria. Exposure to SHS may be an important factor to consider in CKD progression.
Authors: Elaine Urbina; Bruce Alpert; Joseph Flynn; Laura Hayman; Gregory A Harshfield; Marc Jacobson; Larry Mahoney; Brian McCrindle; Michele Mietus-Snyder; Julia Steinberger; Stephen Daniels Journal: Hypertension Date: 2008-08-04 Impact factor: 10.190
Authors: Katariina Kallio; Eero Jokinen; Mauri Hämäläinen; Maiju Saarinen; Iina Volanen; Tuuli Kaitosaari; Jorma Viikari; Tapani Rönnemaa; Olli Simell; Olli T Raitakari Journal: Pediatrics Date: 2009-02 Impact factor: 7.124
Authors: Joseph T Flynn; Mark Mitsnefes; Christopher Pierce; Steven R Cole; Rulan S Parekh; Susan L Furth; Bradley A Warady Journal: Hypertension Date: 2008-08-25 Impact factor: 10.190
Authors: Neal L Benowitz; Katherine M Dains; Delia Dempsey; Brenda Herrera; Lisa Yu; Peyton Jacob Journal: Nicotine Tob Res Date: 2009-06-12 Impact factor: 4.244
Authors: Peter Boor; Sandra Casper; Peter Celec; Marta Hurbánková; Milan Beno; August Heidland; Kerstin Amann; Katarína Sebeková Journal: J Cell Mol Med Date: 2008-10-06 Impact factor: 5.310
Authors: Joseph T Flynn; Derek K Ng; Grace J Chan; Joshua Samuels; Susan Furth; Bradley Warady; Larry A Greenbaum Journal: J Pediatr Date: 2014-03-31 Impact factor: 4.406
Authors: Andrea R Molino; Judith Jerry-Fluker; Meredith A Atkinson; Susan L Furth; Bradley A Warady; Derek K Ng Journal: Pediatr Nephrol Date: 2021-04-29 Impact factor: 3.651
Authors: Andrea R Molino; Judith Jerry-Fluker; Meredith A Atkinson; Susan L Furth; Bradley A Warady; Derek K Ng Journal: Ann Epidemiol Date: 2021-04-22 Impact factor: 6.996